Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Parkinson's Disease

  Free Subscription


1 BMC Neurol
3 J Neural Transm (Vienna)
1 J Neurosci
1 Lancet Neurol
3 Mov Disord
1 Neurology
1 Neuroscience
1 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Neurol

  1. SONG J, Zhang Y, Lang Y, Wang YH, et al
    Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report.
    BMC Neurol. 2021;21:408.
    PubMed         Abstract available

    J Neural Transm (Vienna)

  2. BOCKOVA M, Rektor I
    Electrophysiological biomarkers for deep brain stimulation outcomes in movement disorders: state of the art and future challenges.
    J Neural Transm (Vienna). 2021;128:1169-1175.
    PubMed         Abstract available

  3. CUOCO S, Picillo M, Carotenuto I, Erro R, et al
    The language profile in multiple system atrophy: an exploratory study.
    J Neural Transm (Vienna). 2021;128:1195-1203.
    PubMed         Abstract available

  4. HEIM B, Krismer F, Seppi K
    Differentiating PSP from MSA using MR planimetric measurements: a systematic review and meta-analysis.
    J Neural Transm (Vienna). 2021;128:1497-1505.
    PubMed         Abstract available

    J Neurosci

  5. LAURO PM, Lee S, Akbar U, Asaad WF, et al
    Subthalamic-Cortical Network Reorganization during Parkinson's Tremor.
    J Neurosci. 2021 Oct 25. pii: JNEUROSCI.0854-21.2021.
    PubMed         Abstract available

    Lancet Neurol

  6. RASCOL O, Fabbri M, Poewe W
    Amantadine in the treatment of Parkinson's disease and other movement disorders.
    Lancet Neurol. 2021 Oct 19. pii: S1474-4422(21)00249.
    PubMed         Abstract available

    Mov Disord

  7. VAN RENSBURG ZJ, Abrahams S, Chetty D, Step K, et al
    The South African Parkinson's Disease Study Collection.
    Mov Disord. 2021 Oct 22. doi: 10.1002/mds.28828.
    PubMed         Abstract available

  8. CHARISIS S, Ntanasi E, Stamelou M, Xiromerisiou G, et al
    Plasma Glutathione and Prodromal Parkinson's Disease Probability.
    Mov Disord. 2021 Oct 25. doi: 10.1002/mds.28826.
    PubMed         Abstract available

  9. CORVOL JC, Azulay JP, Bosse B, Dauvilliers Y, et al
    THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial.
    Mov Disord. 2021 Oct 28. doi: 10.1002/mds.28840.
    PubMed         Abstract available


  10. RONG S, Xu G, Liu B, Sun Y, et al
    Trends in Mortality From Parkinson Disease in the United States, 1999-2019.
    Neurology. 2021 Oct 27. pii: WNL.0000000000012826.
    PubMed         Abstract available


  11. LI Z, Lu G, Luo E, Wu B, et al
    Oral, nasal, and gut microbiota in Parkinson's disease.
    Neuroscience. 2021 Oct 22. pii: S0306-4522(21)00513.
    PubMed         Abstract available

    PLoS One

  12. AHN JH, Seok JM, Park J, Jeong H, et al
    Validation of the Korean version of the composite autonomic symptom scale 31 in patients with Parkinson's disease.
    PLoS One. 2021;16:e0258897.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  13. FOUGERE M, van der Zouwen CI, Boutin J, Neszvecsko K, et al
    Optogenetic stimulation of glutamatergic neurons in the cuneiform nucleus controls locomotion in a mouse model of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.